News | Advanced Visualization
February 15, 2018 — The National Institutes of Health (NIH) awarded a $2.2 million research grant to healthcare ...
February 15, 2018
Feature | Heart Valve Technology
February 15, 2018 — Edwards Lifesciences Corp. has received European CE mark clearance for its self-expanding Centera ...
February 15, 2018
Feature | Hemodynamic Support Devices
February 14, 2018 — Abiomed Inc. announced it received an expanded U.S. Food and Drug Administration (FDA) pre-market ...
February 14, 2018Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Technology | Clinical Decision Support
February 14, 2018 — The U.S. Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact ...
February 14, 2018
Feature | Pacemakers | Dave Fornell
There have been several advancements in pacemaker technologies over the past few years. This is an overview of some of ...
February 13, 2018
Abbott announced the first patient has been enrolled in a clinical trial evaluating 28 days of dual antiplatelet therapy (DAPT) in patients at high risk of bleeding after implantation with a Xience everolimus-eluting coronary stent. The first patient was enrolled into the study by Prof. Emanuele Barbato, M.D., Ph.D., a cardiologist at OLV-Hospital Aalst in Belgium.
February 13, 2018Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature | Womens Cardiovascular Health | Jeff Zagoudis
Clinical research has revealed men and women often have different presentations for cardiovascular disease (CVD). This ...
February 12, 2018
News
February 12, 2018 — Philips is recalling the HeartStart MRx Defibrillator due to a defect in the device's Gas Discharge ...
February 12, 2018
Technology | Magnetic Resonance Imaging (MRI)
February 12, 2018 — Physicians now have access to more neuro and cardiac magnetic resonance imaging (MRI) capabilities ...
February 12, 2018Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Cardiovascular Ultrasound
Fox Business News recently featured GE Healthcare’s ultrasound technologies in a 6-minute segment with the Innovations ...
February 09, 2018
Technology | Radiation Dose Management
The Instadose + dosimeter, the latest by Mirion Technologies, transforms radiation monitoring programs to increase ...
February 08, 2018
News | Remote Viewing Systems
February 8, 2018 – Calgary Scientific announced a renewed focus on an enterprise cloud strategy, which will support its ...
February 08, 2018Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | PACS
February 8, 2018 – ScImage, a leading provider of enterprise PACS solutions, is celebrating 25 years of providing ...
February 08, 2018
News | Drug-Eluting Balloons
Medtronic plc recently added to its body of clinical evidence supporting the In.Pact Admiral drug-coated balloon (DCB) with new presentations that demonstrated durable and consistent clinical outcomes in peripheral artery disease (PAD). The new data, presented at the Leipzig Interventional Course (LINC), Jan. 30-Feb. 2, 2018, in Leipzig, Germany, included the two-year results from the MDT-2113 study (IN.PACT SFA Japan) and data from a critical limb ischemia (CLI) subgroup analysis from the IN.PACT Global Study.
February 07, 2018
Feature | Angiography | Dave Fornell
Five new angiography systems were launched in 2017 that included improvements to speed workflow and improve both image ...
February 07, 2018© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now